Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis,

Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis, Drug Discovery and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028

Global Brain Biomarkers Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Brain biomarkers are measurable indicator. These are used to make measurement of brain for diagnosis of diseases related to brains. Brain biomarkers are utilized in the assessment of variety of disease such as stroke, Alzheimer’s Disease, Dementias, Parkinson’s Disease, and Huntington’s Disease among others. Rising prevalence of neurological disorders and increasing technological advancement in the field of biomarkers are key drivers for growth of Brain Biomarkers Market. For instance, as per Pan American Health Organization (PAHO) – As of 2019, In North America, Neurological conditions account for around 533,172 deaths. This constitutes around 213,129 (40%) men, and 320,043 (60%) women. Furthermore, as per European Brain Council, as of 2021, in Europe around 10.5 million people suffered from dementia and this number is projected to increase to 18.7 million by 2050. Also, growing geriatric population and increasing investment in the research and development activities are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of availability of direct-to-consumer testing services impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Brain Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising prevalence of brain disorders such as strokes, Alzheimer’s disease and growing research and development activities in the region. Whereas Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing number of clinical trials being conducted and growing healthcare infrastructure in the region, would create lucrative growth prospects for the Brain Biomarkers market across the Asia Pacific region.

Major market players included in this report are:
Siemens Healthineers
Electrical Geodesics
Lifesign LLC
Advanced Brain Monitoring
BrainScope
GE Healthcare
Johnson & Johnson
Natus Medical
F. Hoffmann-La Roche Ltd.
Qiagen N.V.


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Biomarker Test Kits
Biomarker Analyzers
By Disease Indication
Stroke
MND & ALS
Alzheimer’s Disease & Other Dementias
Parkinson’s Disease
Huntington’s Disease
By Application
Diagnosis
Drug Discovery and Development
Others
By End User:
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Brain Biomarkers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Siemens Healthineers
Electrical Geodesics
Lifesign LLC
Advanced Brain Monitoring
BrainScope
GE Healthcare
Johnson & Johnson
Natus Medical
F. Hoffmann-La Roche Ltd.
Qiagen N.V.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more